Skip to main content
. 2015 Jul 20;121(21):3844–3852. doi: 10.1002/cncr.29575

Table 1.

Descriptive Characteristics of the Study Population

Characteristic Entire Cohort (n = 1070) Training Set: Japanese Cohort (n = 557) Validation Set: Korean Cohort (n = 513) P
Age, mean (SD), y 20.2 (12.9) 20.6 (13.5) 18.5 (10.4) .006
Age, No. (%)
≤12 y 265 (24.8) 136 (24.4) 129 (25.1) .026
13‐19 y 482 (45.0) 236 (42.4) 246 (48.0)
20‐39 y 242 (22.6) 131 (23.5) 111 (21.6)
≥40 y 81 (7.6) 54 (9.7) 27 (5.3)
Sex, No. (%)
Male 677 (63.3) 344 (61.8) 333 (64.9) .285
Female 393 (36.7) 213 (38.2) 180 (35.1)
Tumor size, mean (SD), cm 9.8 (4.1) 9.7 (4.1) 9.9 (4.1) .329
Tumor size, No. (%)
≤8 cm 450 (42.1) 246 (44.2) 204 (39.8) .145
>8 cm 620 (57.9) 311 (55.8) 309 (60.2)
Location, No. (%)
Distal extremity 70 (6.5) 42 (7.5) 28 (5.5) .520
Distal femur 476 (44.5) 251 (45.1) 225 (43.9)
Proximal tibia/fibula 304 (28.4) 151 (27.1) 153 (29.8)
Proximal humerus 96 (9.0) 47 (8.4) 49 (9.6)
Proximal femur 77 (7.2) 38 (6.8) 39 (7.6)
Trunk 47 (4.4) 28 (5.0) 19 (3.7)
Pathologic fracture, No. (%)
No 978 (91.4) 516 (92.6) 462 (90.1) .132
Yes 92 (8.6) 41 (7.4) 51 (9.9)
Histologic response (tumor necrotic rate), No. (%)
Grade 1 (<50%) 244 (22.8) 144 (25.9) 100 (19.5) .013
Grade 2 (50%‐89%) 357 (33.4) 168 (30.2) 189 (36.8)
Grade 3 (90%‐99%) 322 (30.1) 176 (31.6) 146 (28.5)
Grade 4 (100%) 147 (13.7) 69 (12.4) 78 (15.2)

Abbreviation: SD, standard deviation.